Download our newest whitepaper to learn more about the trends reshaping the world economy, the potential impact on future earnings growth, and how our portfolio managers think about investing amid disruption.
The right side of disruption
Fixed Income in Retirement Plan Lineups: When Traditional Risk Assessment Methods Fall Short
Why using traditional methods to assess the risks associated with certain diversifying fixed income categories may prove to be problematic.
Back to Basics: Three Steps to Reinvigorate Your Client Relationships
Making meaningful connections with clients is the foundation of any successful practice – particularly during times of crisis. Michael Futterman, Head of Knowledge Labs® Professional Development discusses.
REITs: A Diversification Trilogy
Can a portfolio allocation to REITs help ease client concerns around market uncertainties?
Beating the biotech blues
The biotech sector is experiencing its worst period of relative underperformance on record. But some of history’s biggest biotech pains have been followed by memorable gains.
Banishing Burnout: How to Support Your Team
The roots of burnout run deep but are usually hidden from view, making it difficult to detect in others before it’s too late.
Beating the biotech blues
The biotech sector is experiencing its worst period of relative underperformance on record. But some of history’s biggest biotech pains have been followed by memorable gains.
Perspectives Test article Conor/Jazz/Milo
Category from Word Doc Chris Herringshaw Chief Technology Officer Olivia Hails, APMA® Director, Advisor Solutions Group Madeline Saldutti Internal Sales Consultant Kelly Hagg Global Head of Product Strategy and ESG Nick Sandford, FRM Risk Analyst Emmanuel Cahn Sales Manager Dan Fox Sr. Director Sara Tegethoff Lowery, CRPC® Retirement Director Jack Yuan, PhD – REMOVED Deputy
With early-cycle behind us, securities must stand on own merits
With index-level valuations high, equity investors should focus on individual companies to generate attractive future returns, Director of Research Matt Peron argues.
Understanding the impact of Delta
The highly infectious variant of COVID-19 has led to rising case numbers, but we explain why a return to normalcy is still within striking distance.